Prenatal Vitamin D Supplementation Increases Bone Density in Children
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 15, 2024 -- Supplementation with cholecalciferol 1,000 IU/day during pregnancy is associated with greater offspring bone mineral density during childhood, according to a study published in the November issue of the American Journal of Clinical Nutrition.
Rebecca J. Moon, B.M., B.Sc., from the University of Southampton in the United Kingdom, and colleagues examined whether gestational vitamin D supplementation increases offspring bone mineral density at ages 6 to 7 years in a post-hoc analysis of the Maternal Vitamin D Osteoporosis Study randomized controlled trial. Pregnant women at <14 weeks of gestation with a singleton pregnancy and serum 25-hydroxyvitamin D of 25 to 100 nmol/L were randomly assigned to receive 1,000 IU/day cholecalciferol or placebo from 14 to 17 weeks of gestation until delivery. Offspring born to participants were invited to the childhood follow-up at ages 4 and 6 to 7 years. A total of 454 children were followed up at age 6 to 7 years; 447 had a usable dual-energy X-ray absorptiometry scan.
The researchers found that compared with placebo, gestational cholecalciferol supplementation resulted in significantly higher whole-body-less-head bone mineral content, bone mineral density, bone mineral apparent density, and lean mass. At ages 4 and 6 to 7 years, the effect of pregnancy cholecalciferol on bone outcomes was similar.
"This early intervention represents an important public health strategy," Moon said in a statement. "It strengthens children's bones and reduces the risk of conditions like osteoporosis and fractures in later life."
Several authors disclosed ties to pharmaceutical and nutrition companies, including Merck, which provided the supplement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Specific Antiseizure Medications Associated With Major Malformations in Infants
FRIDAY, July 18, 2025 -- Maternal use of valproate, phenobarbital, and topiramate early in pregnancy is associated with an increased risk for major malformations in infants...
ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes
FRIDAY, July 18, 2025 -- In a joint clinical practice guideline issued by the Endocrine Society and European Society of Endocrinology, recommendations are presented for pregnancy...
Vitamin D3 Supplementation Reduces Telomere Attrition
MONDAY, June 2, 2025 -- Supplementation with vitamin D3 is associated with reduced telomere attrition in adults aged 50 years and older, according to a study published online May...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.